Ferreira Juan Camilo Arjona
CIK 1714080 · Head of R&D & CMO · last filed 2026-04-02
Ferreira Juan Camilo Arjona is a Head of R&D & CMO who has filed 51 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for OGN, was dated Apr 2, 2026. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $468.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$468.6K
2
51
-$3.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGN | Head of R&D & CMO | 34,867 | $13.44 | $468.6K | $0 | 8 | 2026-04-02 |
| Myovant Sciences Ltd. (MYOV) Delisted | Chief Medical Officer | 0 | $26.98 | $0 | -$3.91M | 43 | 2023-03-10 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-02 | OGN | Mixed | +8,611 | -$27.5K | EDGAR |
| 2026-03-31 | OGN | Mixed | +5,684 | -$18.6K | EDGAR |
| 2025-11-10 | OGN | Mixed | +4,139 | -$15.5K | EDGAR |
| 2025-08-12 | OGN | Mixed | +7,397 | -$38.0K | EDGAR |
| 2025-04-02 | OGN | Mixed | +5,693 | -$46.0K | EDGAR |
| 2024-11-08 | OGN | Mixed | +4,146 | -$36.3K | EDGAR |
| 2024-08-12 | OGN | Mixed | +7,528 | -$80.4K | EDGAR |
| 2024-04-16 | OGN | Grant (A) | — | $0 | EDGAR |
| 2023-03-10 | Myovant Sciences Ltd. (MYOV) Delisted | Disp (D) | −246,684 | $0 | EDGAR |
| 2023-01-20 | Myovant Sciences Ltd. (MYOV) Delisted | Sell (S) | −1,109 | -$29.8K | EDGAR |